Ganderton M A, James V H
Br Med J. 1970 Jan 31;1(5691):267-9. doi: 10.1136/bmj.1.5691.267.
Eight patients were treated with two 80-mg. doses of methylprednisolone acetate (Depo-Medrone), given at an interval of two weeks. Pituitary-adrenal function was assessed before, during, and after treatment.Plasma cortisol levels were depressed maximally 72 hours after each injection of methylprednisolone acetate, and then gradually returned to normal. The adrenocortical response to administered corticotrophin was similarly affected; in seven patients normal values were again recorded three weeks after the second injection of methylprednisolone acetate. One patient whose adrenal function had returned to normal still showed some degree of pituitary suppression eight weeks after his second injection. Several side-effects were noted, and clinically the patients fared less well than a larger series studied during the previous year.
八名患者接受了两次80毫克醋酸甲泼尼龙(得宝松)治疗,间隔两周给药一次。在治疗前、治疗期间和治疗后评估垂体-肾上腺功能。每次注射醋酸甲泼尼龙后72小时血浆皮质醇水平降至最低,然后逐渐恢复正常。肾上腺皮质对促肾上腺皮质激素给药的反应也受到类似影响;在七名患者中,第二次注射醋酸甲泼尼龙三周后再次记录到正常值。一名肾上腺功能已恢复正常的患者在第二次注射八周后仍表现出一定程度的垂体抑制。观察到了几种副作用,临床上这些患者的情况比上一年研究的更大样本系列要差。